Generex nach aktiendividende

BOTTOM LINE
Generex Biotechnology meteoric rise to the top has not come on speculation but on investors taking note of the aggressive acquisition drive as well as strengthening fundamentals. The company diversifying its operation with expansion into the cannabis space is another development that continues to fuel the upward momentum.

If you are looking for a fast growing stock in the health sciences space, then Generex Biotechnology is an ideal pick, given the plenty of opportunities on the horizon. After a 600% spike, it might be wise to wait for a pullback before entering a long position in the stock.